Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The world is facing a significant challenge with the increasing prevalence of chronic diseases and genetic disorders. According to the Centers for Disease Control and Prevention (CDC), in 2019, about 60% of adults globally were dealing with chronic diseases, and this percentage is even higher among elderly individuals. Shockingly, it's estimated that around 70% of adults will eventually succumb to one or more chronic diseases. The situation is alarming as it poses a serious threat to public health.
To provide some context, in the United States alone, a staggering 84.1 million people were diagnosed with prediabetes in 2019. This condition is a precursor to more severe health issues like diabetes. Furthermore, chronic lung disease affects one in every five premature babies, underscoring the vulnerability of the youngest members of our population. Breast cancer is also a prevalent concern, with one in every eight women being diagnosed with this disease.
As individuals age, the likelihood of facing chronic diseases increases. According to CHRODIS PLUS, an initiative funded by the European Commission and other organizations, a striking eight out of ten people aged 65 and above suffer from one or more chronic diseases. These conditions include heart disease, stroke, cancer, diabetes, and Alzheimer's disease. The economic impact of chronic diseases is substantial, with European Union (EU) economies spending a massive 115 billion euros annually, equivalent to almost 0.8% of their GDP. Notably, a significant portion, ranging from 70-80%, is allocated to the treatment of chronic diseases.
Turning our attention to genetic disorders, there are over 10,000 different types globally, caused by abnormalities in one or more genes. These disorders often run in families, meaning they can be inherited by children from their parents. The Royal Society's case study in 2017 revealed that over half a million people in the United Kingdom alone were diagnosed with a genetic disorder, emphasizing the widespread impact of these conditions. Some genetic disorders, like familial hypercholesterolemia, are more prevalent in certain regions. For instance, in the UK, around 0.4% of the population, or 1 in 250 people, are affected by familial hypercholesterolemia. Additionally, certain disorders are rarer but more common in specific ethnic groups, such as cystic fibrosis, which affects a higher number of people in Scotland compared to the global average.
The causes of genetic disorders extend beyond gene mutations and can include environmental factors and chromosomal damage. This complexity underscores the challenges associated with addressing and preventing these conditions. While methods like DNA sequencing, gene therapy, and genome editing are emerging as potential solutions, there is a growing interest in regenerative medicine. This field holds promise for treating and mitigating the impact of both chronic diseases and genetic disorders. As the demand for regenerative medicine continues to rise, it is expected to drive market growth in the coming years, offering hope for improved health outcomes and a better quality of life for individuals facing these health challenges.
Automated Cell Culture Equipment Market Highlights:
Automated Cell Culture Equipment Market Overview
Automated Cell Culture Equipment Market Size was valued at USD 0.90 Billion in 2023. The Automated Cell Culture Equipment industry is projected to grow from USD 0.97 Billion in 2024 to USD 1.71 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.43% during the forecast period (2024 - 2032). Biological experimentation and drug origination are the two basic extents of cell culture. Handling the sterile solution is a cumbersome task and is very much prone to spoilage. This process of handling and transporting the solution to different containers can be made easy through automated cell culture systems. With the help of improved technology and automated cell culture equipment, the cultivation and preservation of cells and tissues in desired circumstances have become easier. An automated cell culture system guarantees uniformity in the process. The process becomes more cost-effective and less time-consuming. Through this system, a lab technician can also monitor and record developments easily.
Covid19 Analysis
Researchers from across the globe are working on developing a vaccine or an antidote for the coronavirus. The strains of SARS-Cov-2 are obtained from a patient’s body and then the researchers work on the automated cell culture system to extract the primary and stem cell lines from the samples obtained. This sudden surge in the field of pharmaceuticals and its related Research & Development has increased the automated cell culture equipment market share. This equipment is needed for rapid testing and trial of coronavirus.
Market Dynamics
Drivers
The widespread presence of chronic diseases such as cancer, HIV, Tuberculosis, calls for the requirement of new and useful drugs. In a report, the National Cancer Institute indicated that the estimated number of cases of cancer diagnosed and reported in the US in 2018 was 1,735,350. The numbers are sloping upwards in every part of the world. This will increase the automated cell culture market share.
Opportunities
The hike in the number of tests being done regularly due to the prevalent infectious diseases leads to the increased demand for testing and research equipment. As the automated cell, culture systems are time and cost-effective, the results can be drawn instantly. This has increased automated cell culture equipment market size.
Restraints
The environment is dynamic as changes are occurring in the blink of an eye. There is a dearth of skilled workers who can operate the instruments and machines. Automated cell culture systems can prove to be cost-effective in the long run but their maintenance is a costly affair.
Value Chain Analysis
Automated cell culture equipment reduces all the redundant activities on part of the workers. It has decreased manual labor. It also ensures uniformity and consistency in managing the material. It, thus, ensures the quality of the research and the material. The efficiency is also increased as several people can work on the same samples but the outcomes will not fluctuate.
Market Segmentation
Automated cell culture market share can be classified into various segments. These are: based on lab automation type, based on product type, based on application, and based on end-user.
Based on lab automation type:
It can be further subdivided into two types, namely, modular automation and whole lab automation. The modular automation is anticipated to capture the largest automated cell culture equipment market share of 67.20% by the end of the year 2025. It is helpful in pre-clinical trials as well as in-depth research. Whole lab automation helps in sample arrangements as well as screening.
Based on product type:
An automated cell culture system provides three types of products, namely, consumables, equipment, and software. The software runs through the computer system and enables the lab technicians to give commands and gets desired results. Consumables are the products that need constant supplies as they are to be replaced with every use. Equipment is necessary to carry on the research process.
Based on application:
Automated cell culture equipment can be easily applied to different fields such as biopharmaceutical productions, vaccine production, tissue engineering, stem cell therapy, and toxicity testing, general diagnosis, drug screening and development, and others.
Based on end-user:
Pharmaceutical and biotechnological industries, hospitals and diagnostic labs, pathological labs, research, and academic institutes comprise automated cell culture equipment market size. This equipment is required in the labs for regular testing, maintaining records as well as monitoring the results.
Regional Analysis
The automated cell culture market is leaving its impression in every corner of the world. The regions include America, Europe, Asia-pacific, Middle-East, and Africa.
The automated cell culture equipment market share in America can be divided into North America, which can further be divided in the US and Canada, and Latin America. America, having a large population, robust healthcare infrastructure, and due to the increase in Research & Development, is the greatest consumer of automated cell culture equipment. America alone had a market share of 42.54% in the year 2018. It is expected that this share will increase double folds in the coming years
The European market can be further segmented into Western Europe, which has further branches in Germany, France, Italy, UK, Spain, and Eastern Europe. Europe is the second-largest customer of automated cell culture equipment.
In Asia-pacific regions, the branches can be seen in the areas such as China, India, Japan, South Korea, and Australia. It holds the third-largest position in the automated cell culture equipment market share. It is also estimated to grow tremendously throughout the forecast.
The Middle East and Africa are growing at a slower pace but will provide a promising automated cell culture equipment market in the coming future. This is because there are many developing nations in this region.
Competitive Landscape
The list of major key players involved in the automated cell culture equipment market research is as follows:
- Tecan Trading AG
- Siemens
- Pfizer Inc.
- Hitachi, Ltd
- Thermo Fisher Scientific Inc.
- Sartorius AG
- Hamilton Company
- Beckman Coulter, Inc.
- F. Hoffmann-La Roche Ltd.
- Perkinelmer, Inc.
- Anton Paar GmBH.Becton, Dickinson, and Company (U.S.)
- HiMedia Laboratories (India)
- GE Healthcare (U.S.)
- Lonza (Switzerland)
- CellGenix GmbH (Germany).
The above-listed companies work on the screening and development of new as well as useful drugs. They invest in the latest technologies to perform the tasks more effectively and efficiently. Automated cell culture systems provide them with equipment that increases the feasibility of their processes and thus, gives durable outcomes.
Recent Development
Various developments are seen in the automated cell culture equipment market which is as follows:
- In the year 2020, a japan based biotechnical organization named ThinkCyte Inc., came in a joint venture with Hitachi to develop an artificial intelligence system for strengthening cell analysis.
- In the year 2019, Thermo Fisher introduced a new automated incubator for delivering and maintaining cells and microorganisms in a controlled environment.
- In June of 2020, ThermoGnesis Corp., a pharmaceutical company, launched an X-series cell culturing products at a commercial level.
- In May of 2019, Sartorius AG brought into being an automated micro-bioreactor, called Ambr 15 Cell Culture.
- In the year 2020, HORIBA Medical and CellaVision collaborated and produced an automated digital cell morphology solution.
Report Overview
This market research report of automated cell culture equipment market includes the following elements:
- Automated Cell Culture Equipment Market Overview
- COVID19 Analysis
- Market Dynamics
- Value Chain Analysis
- Automated Cell Culture Equipment Market Segmentation
- Regional Analysis
- Competitive Landscape
- Recent Developments
This automated cell culture equipment market research report enumerates how the cell culture system works. The automation of the cell culture system will give certain benefits to the companies. It will lead to more accuracy in the functioning; it will reduce the cost and time, and it will lower the chances of inaccuracy and miscalculations. The widespread presence of chronic diseases such as cancer, HIV, Tuberculosis, calls for the requirement of new and useful drugs. It becomes the major driving force of the automated cell culture equipment market. It has decreased the manual labor and redundant activities by the workers.
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
